Reversible cardiomyopathy due to chronic use of xylometazoline topical nasal spray.
Lourdes M
LM
Figueiras-Graillet
Manuel
M
Martínez-Sellés
Esther
E
Perez-David
Francisco
F
Fernandez-Avilés
D000280:Administration, Inhalation; D000287:Administration, Topical; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000009:adverse effects*; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000175:diagnosis*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D014663:Nasal Decongestants / Q000008:administration & dosage / Q000009:adverse effects*
D000316:Adrenergic alpha-Agonists; D007093:Imidazoles; D014663:Nasal Decongestants; C009695:xylometazoline